Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial
Year: 2025
Type: article
Source: Heart
Authors: Min Soo Cho, Do-Yoon Kang, Jung-Bok Lee, Yong-Seog Oh, Chang Hoon Lee, Eue-Keun Choi, Ji Hyun Lee, Chang Hee Kwon, Gyung-Min Park, Hyung Oh Choi, Kyoung-Ha Park, Kyoung-Min Park, Jongmin Hwang, Ki-Dong Yoo, Young Rak Cho, Ji-Hyun Kim, Ki Won Hwang, Eun Sun Jin, Osung Kwon, Ki-Hun Kim, Duk-Woo Park, Gi-Byoung Nam
Institutions: Asan Medical Center, Seoul National University Bundang Hospital, The Catholic University of Korea Seoul St. Mary's Hospital, Veterans Health Service Medical Center, Seoul National University Hospital, Konkuk University Medical Center, Ulsan University Hospital, Soonchunhyang University Hospital Bucheon, Samsung Medical Center, Hallym University Medical Center, Keimyung University Dongsan Hospital, The Catholic University of Korea St. Vincent's Hospital, Catholic University of Korea, Dong-A University Hospital, Dong-A University, Dongguk University Ilsan Hospital, Pusan National University Yangsan Hospital, Kyung Hee University Hospital at Gangdong, The Catholic University of Korea Eunpyeong St. Mary's Hospital, Inje University Haeundae Paik Hospital, University of Ulsan
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414153040